Kestra Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,918
| Closed | -$166K | – | 2676 |
|
|
2024
Q1 | $166K | Sell |
11,918
-599
| -5% | -$8.32K | ﹤0.01% | 2315 |
|
|
2023
Q4 | $179K | Buy |
12,517
+353
| +3% | +$5.04K | ﹤0.01% | 2130 |
|
|
2023
Q3 | $188K | Sell |
12,164
-259
| -2% | -$4.01K | ﹤0.01% | 1932 |
|
|
2023
Q2 | $195K | Sell |
12,423
-6,781
| -35% | -$107K | ﹤0.01% | 1911 |
|
|
2023
Q1 | $316K | Sell |
19,204
-17,492
| -48% | -$288K | ﹤0.01% | 1530 |
|
|
2022
Q4 | $572K | Buy |
36,696
+10,041
| +38% | +$157K | 0.01% | 1326 |
|
|
2022
Q3 | $346K | Buy |
26,655
+761
| +3% | +$9.88K | ﹤0.01% | 1525 |
|
|
2022
Q2 | $364K | Buy |
25,894
+3,925
| +18% | +$55.2K | ﹤0.01% | 1506 |
|
|
2022
Q1 | $315K | Sell |
21,969
-6,619
| -23% | -$94.9K | ﹤0.01% | 1568 |
|
|
2021
Q4 | $390K | Sell |
28,588
-7,940
| -22% | -$108K | ﹤0.01% | 1450 |
|
|
2021
Q3 | $598K | Sell |
36,528
-330
| -0.9% | -$5.4K | 0.01% | 1292 |
|
|
2021
Q2 | $620K | Sell |
36,858
-926
| -2% | -$15.6K | 0.01% | 1171 |
|
|
2021
Q1 | $690K | Buy |
37,784
+25,054
| +197% | +$458K | 0.01% | 1038 |
|
|
2020
Q4 | $231K | Buy |
+12,730
| New | +$231K | ﹤0.01% | 1627 |
|